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Antibiotic use among patients with febrile illness
in a low malaria endemicity setting in Uganda
Vincent Batwala1,3*, Pascal Magnussen2 and Fred Nuwaha3
Abstract
Background: Uganda embraced the World Health Organization guidelines that recommend a universal ‘test and
treat’ strategy for malaria, mainly by use of rapid diagnostic test (RDT) and microscopy. However, little is known
how increased parasitological diagnosis for malaria influences antibiotic treatment among patients with febrile
illness.
Methods: Data collection was carried out within a feasibility trial of presumptive diagnosis of malaria (control) and
two diagnostic interventions (microscopy or RDT) in a district of low transmission intensity. Five primary level
health centres (HCs) were randomized to each diagnostic arm (diagnostic method in a defined group of patients).
All 52,116 outpatients (presumptive 16,971; microscopy 17,508; and RDT 17,638) aged 5 months to ninety five years
presenting with fever (by statement or measured) were included. Information from outpatients and laboratory
registers was extracted weekly from March 2010 to July 2011. The proportion of patients who were prescribed
antibiotics was calculated among those not tested for malaria, those who tested positive and in those who tested
negative.
Results: Seven thousand and forty (41.5%) patients in the presumptive arm were prescribed antibiotics. Of the
patients not tested for malaria, 1,537 (23.9%) in microscopy arm and 810 (56.2%) in RDT arm were prescribed
antibiotics. Among patients who tested positive for malaria, 845 (25.8%) were prescribed antibiotics in the RDT and
273(17.6%) in the microscopy arm. Among patients who tested negative for malaria, 7809 (61.4%) were prescribed
antibiotics in the RDT and 3749 (39.3%) in the microscopy arm. Overall the prescription of antibiotics was more
common for children less than five years of age 5,388 (63%) compared to those five years and above 16798 (38.6%).
Conclusion: Prescription of antibiotics in patients with febrile illness is high. Testing positive for malaria reduces
antibiotic treatment but testing negative for malaria increases use of antibiotics.
Trial Registration: ClinicalTrials.gov: NCT00565071
Keywords: Antibiotic treatment, febrile patients, malaria diagnosis
Background
Recent World Health Organization (WHO) guidelines
recommend a universal ‘test and treat’ strategy for
malaria, mainly by use of rapid diagnostic test (RDT)
and microscopy in all transmission areas [1]. In rural
settings, however, febrile outpatients present with multi-
ple complaints at health facilities and receive antibiotics
in addition to anti-malarial treatment. Although WHO
recommends rational use of medicines, it is estimated
that in developing countries, the proportion of patients
treated according to clinical guidelines for common dis-
eases in primary care is less than 40% in the public sec-
tor and 30% in the private sector [2].
Antibiotics are routinely prescribed for colds, non-spe-
cific upper respiratory tract infections and acute bronchi-
tis [3,4], as concomitant medications to anti-malarials
[5]. In almost all cases, these are viral, self-limited condi-
tions in which antibiotic use does not enhance illness
resolution and is not recommended [6,7]. For other
infections, such as otitis media, antibiotics provide some
benefit, but the value of their use as first-line treatment
has been debated [8].
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Even for conditions in which antibiotic use might be
justified, experts have expressed concern about substan-
tial overuse [4] that impacts on health care costs. Inap-
propriate use of these drugs promotes antimicrobial
resistance [9], adverse drug reactions and erodes patient
confidence in health services [2]. In absence of urgent
and corrective actions, the world is heading towards a
post-antibiotic era in which many common infections
will no longer have a cure and, once again, kill unabated
[10,11].
Although the Uganda national malaria guidelines now
recommend confirmation of parasitaemia before initiation
of treatment, data on how results of use of malaria diag-
nostics influence antibiotic treatment among febrile outpa-
tients is lacking. The current study assessed antibiotic
prescribing rates among febrile outpatients attending rural
health centres (HCs) where feasibility of rolling out parasi-
tological diagnosis for malaria was being tested. The pri-
mary outcome measures were the proportions of patients
with febrile illness that were prescribed antibiotics when:
not tested for malaria, they test positive and when they
test negative.
Methods
Study design
Data collection on antibiotic treatment was carried out
within a cluster randomized feasibility trial of presump-
tive malaria diagnosis (control) and two diagnostic inter-
ventions (microscopy and RDT). Fifteen out of twenty
sub-county level government HCs in a district of low
malaria endemicity in Uganda were randomly selected
for the trial. HCs were the primary sampling units, and
were allocated to the three diagnostic arms using simple
randomization. Finally, there were five HCs per arm
(diagnostic method in a defined group of patients).
Setting
The trial was carried out in Bushenyi district in south-
western Uganda. The district headquarter is located at
about 320 km from the capital city Kampala. The district
is mainly rural with a total land area of 3,949 sq. km. It is
endowed with diverse natural resources that include ara-
ble land, forests, large lake water bodies (Lakes Edward,
George and Kazinga Channel), Queen Elizabeth National
Park and minerals. The main economic activities are
semi-intensive agriculture (growing crops and rearing
animals), fishing and trade. The district is multi-ethnic
with varying customs and norms. The main inhabitants
are Banyankore and Bakiga. The total population is esti-
mated at 731,392, and with 20 public HCs at sub-county
level. The population distribution and density varies with
physical geography. It is concentrated in the low-lying
plateau zones of Sheema, Igara and Ruhinda; and sparse
in the hilly-rough and rugged terrain of Buhweju and
Bunyaruguru. The climate is relatively wet. The mean
annual temperature range is 12.5°-30°C. Most of the dis-
trict receives 1500-2000 mm of rainfall annually.
Although Bushenyi experiences low and unstable malaria
transmission, people of all ages are at risk. It is epidemic-
prone, with occasional malaria outbreaks occurring
shortly after the rains. The annual entomological inocula-
tion rate is not known, but it was reported to be < 10
infective bites per person per year in the neighbouring
district of Kanungu [12]. The trial commenced before
Bushenyi was partitioned. However, partitioning did not
affect the status of the trial HCs and the delivery of
health services by the end of data collection. Additional
description of the study setting has been published pre-
viously [13].
Study procedures
Training of staff
A total of 74 clinical and laboratory staff received a one-
day refresher training on-site. The training and subse-
quent study procedures were a scale-up of activities
performed during the assessment of the accuracy of
these malaria diagnostic methods [14]. All staff members
were trained in theory by re-orienting them to the
malaria treatment policy. Staff in the control arm were
only re-oriented to the current malaria treatment guide-
lines but testing of patients was not performed. In the
microscopy arm, members were, in addition, trained in
1) finger prick for collection of blood, 2) thick/thin
blood smear preparation, 3) staining smears, and 4)
blood smear reading. In the RDT arm, the staff were in
addition, trained in 1) finger prick for collection of
blood and 2) preparation and reading of Paracheck®.
The staff in HCs with microscopy or RDT were
instructed to treat patients for malaria according to test
results. Treatment with antibiotics followed national
guidelines. HC outpatient registers were modified to
record additional variables such as the presenting com-
plaints, drugs dispensed and to indicate those prescribed
but out-of stock. The trained staff were charged with
training those that were off-duty on the day of training.
However, additional clarification was provided during
supervision. Supervision by the study team was carried
out weekly during the first two months and monthly
thereafter. The district laboratory focal persons provided
the routine quality control procedures in both micro-
scopy and RDT arms.
Description of the diagnostic arms
Presumptive (control) arm
Patients presenting with fever (by statement or mea-
sured) were enrolled to receive service without parasito-
logical confirmation of malaria. Patients were treated on
the basis of signs and symptoms only.
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Microscopy arm
All patients presenting with fever (by statement or
measured) were enrolled. The laboratory assistants
prepared thick and thin blood smears by finger-prick
using sterile blood lancets on separate frosted slides.
Standard staining was performed using the Field’s stain
method. Laboratory assistants were only familiar with
this staining technique. Blood films were read at mag-
nification X1,000. Each film was graded as positive
(asexual malaria parasites seen) or negative (no malaria
parasites seen) based on inspection of 200 fields.
Microscopy test results were recorded in the laboratory
registers.
Rapid diagnostic test arm
Patients presenting with fever underwent rapid testing
with the “Paracheck®“ device (Orchid Biomedical Sys-
tems, Goa, India). Paracheck Pf® is based on the detec-
tion of histidine rich protein-2 (Pf HRP-2) produced by
Plasmodium falciparum trophozoites and young game-
tocytes. The specimens were drawn by trained nurses or
laboratory assistants using a simple finger-prick. The
test preparation and interpretation were done following
manufacturer’s instructions and standard operating pro-
cedures. The test was considered positive when the anti-
gen line was visible in the test window and negative
when only the control band was visible. RDT results
were recorded in the outpatient registers.
Data collection
All outpatients presenting at the study HCs with fever
(by statement or measured) from March 2010 to July
2011 were enrolled. Data collection was carried out
weekly by the research assistants by extracting informa-
tion from the laboratory and outpatient registers.
Statistical analysis
The collected data were manually checked and cleaned.
Data were double entered by two trained database assis-
tants in a customized entry template with in-built con-
sistency checks in EpiData 3.1 software (The EpiData
Association, Odense, Denmark). The two data sets were
validated to check for entry errors. Before analysis in
Stata version 10 (Stata Corp LP, College Station, Texas,
USA), the data were declared a cluster design using the
“svyset command” with HCs as primary sampling units.
Further, the Poisson regression model was fitted while
accounting for clustering. Probability values (p-values)
were set at 0.05 and confidence intervals (CI) were cal-
culated at the 95% level. Socio-demographic and symp-
tom data were presented using descriptive statistics:
distribution by age, number and percent of patients
with positive and negative results, and those receiving
drugs.
Ethical approval
The study was approved by Makerere University School
of Public Health Higher Degrees Research and Ethics
Committee; and the Uganda National Council for
Science and Technology (Ref: HS 209). The study was
registered with the Clinicaltrials.gov (NCT00565071).
Results
Description of the study population
The study was carried out in 15 sub-county level gov-
ernment HCs located in an area of low malaria trans-
mission intensity. Overall, 52,116 outpatients presenting
with fever were enrolled: in the presumptive arm 16,971;
microscopy arm 17,508; and RDT arm 17,637 (Figure 1).
There were 8,552 children under five years (16.4%) with
a median age of two [inter-quartile range one to three
years]. The median age for those five years and above
was 21 [inter-quartile range 13-34 years]. The overall
age range was five months to ninety five years. The pre-
senting symptoms of patients are presented in Table 1.
Types of antibiotics prescribed
Oral co-trimoxazole was prescribed to 11,862 patients
(51.0%) and amoxicillin capsules to 5,986 (25.8%). These
two antibiotics were the most commonly prescribed.
Metronidazole was prescribed to 3,950 patients (17.0%),
but in combination with other antibiotics. Doxycycline,
erythromycin and ciprofloxacin were also prescribed,
but in smaller quantities. Other drugs such as analgesics
and anti-helminthics were prescribed to 49,574 patients
(95.2%) and 10,330 (19.8%) respectively.
Antibiotic use in patients who did not receive a
parasitological test for malaria
In the presumptive arm 7,040 patients (41.5%) were pre-
scribed antibiotics. In the microscopy arm 6,427 (37%) did
not receive a parasitological diagnosis and of these 1,537
(23.9%) were prescribed antibiotics. In the RDT arm, 1442
(8%) did not receive a parasitological diagnosis and of
these 810 (56.2%) were prescribed antibiotics (Figure 1).
Prescription of antibiotics was more common for children
less than five years of age as compared to those who were
older (Table 2). The pattern of antibiotic prescription var-
ied widely across health units: presumptive arm (range
40.7% to 42.2%), microscopy arm (range 22.9% to 25.0%)
and in RDT arm (range 53.6% to 58.7%). Overall 9387
(38%) of the patients who did not receive a parasitological
diagnosis were prescribed antibiotics.
Antibiotic treatment in patients with a positive RDT or
microscopy
Of the 3,313 patients who tested positive for malaria in
the RDT arm, 854 (25.8%) were prescribed antibiotics. In
the microscopy arm of the 1,548 with positive results,
Batwala et al. Malaria Journal 2011, 10:377
http://www.malariajournal.com/content/10/1/377
Page 3 of 8
273 (17.6%) were prescribed antibiotics (Table 3).
Patients under five years were more often prescribed
antibiotics than in those five years and above in both
RDT and microscopy arms. Prescription of antibiotics
also varied widely between health units (ranging from
15.7% to 27.3%).
Antibiotic use in patients with negative RDT or
microscopy
Overall, 11,658 patients (52.1%) with negative results
were prescribed antibiotics (Table 4). Patients with
negative RDT 7,909 (61.4%) received antibiotics
prescription more often than those with negative
Table 1 Selected characteristics of study sample
Characteristic Presumptive (%) [Int. range] RDT
(%) [Int. range]
Microscopy
(%) [Int. range]
Level at the health delivery system Sub-county Sub-county Sub-county
Number of health centres per arm 5 5 5
Total enrolment 16971 17637 17508
Gender (female) 10007(59.0) 10045(57.0) 10440(59.6)
Median age (in years)
< 5 years 2 [1-3] 2 [1-3] 1.1 [1-3]
≥ 5 years 21 [13-34] 22 [14-35] 20 [13-34]
Non-specific URTI
< 5 years 1554(52.9) 1626(59.9) 1350(46.6)
≥ 5 years 3635(25.9) 5432(36.4) 2643(18.1)
Otitis media
< 5 years 6(0.2) 16(0.6) 20(0.7)
≥ 5 years 24(0.2) 8(0.1) 24(0.2)
Sore throat
< 5 years 24(0.8) 8(0.3) 24(0.8)
≥ 5 years 20(0.1) 204(1.2) 136(0.9)
Int. range = inter-quartile range, RDT = rapid diagnostic test, URTI = upper respiratory tract infection
 
 
 
 
 
 
 
 
 
 
 
 
 
Abs = antibiotics, RDT=rapid diagnostic test 
Enrolled 
52116 
Presumptive 
16971 
Abs 
7040 
Microscopy 
17508 
Tested 
11081 
Positive 
1548 
Abs 
273 
Negative 
9533 
Abs 
3749 
Not tested 
6427 
Abs 
1537 
RDT 
17637  
Not tested 
1442 
Abs 
810 
Negative 
12882 
Tested 
16195 
Positive 
3313  
Abs 
854 
Abs 
7909 
Figure 1 Study profile.
Batwala et al. Malaria Journal 2011, 10:377
http://www.malariajournal.com/content/10/1/377
Page 4 of 8
microscopy results 3,749 (39.3%) [RR: 1.56; 95%CI: 1.41-
1.73, p < 0.001]. Again children under five years of age
with negative results in both RDT and microscopy arms
were more often prescribed antibiotics than the older
age group. Further, antibiotic prescription varied widely
across health units (ranging from 38.4% to 62.4%).
Discussion
This article reports on a large assessment of the effect of
malaria diagnostics on the probability of receiving anti-
biotics in a Ugandan population living in an area of
unstable malaria transmission. The findings indicate that
the rate of antibiotic treatment was high; there was a
Table 2 Prescription of antibiotics in patients who did not receive parasitological diagnosis stratified by diagnostic
method, age and health centre
Diagnostic method < 5 years
n(%)[95%CI]
≥ 5 years
n(%)[95%CI]
Total
n(%)[95%CI]
Presumptive
Karungu 372(69.9) [66.0-73.8] 1327(39.0) [37.4-40.7] 1699(43.2) [41.6-44.7]
Kashenshero * 1136(34.7) [33.1-36.3] 1136(34.7) [33.0-36.3]
Katunguru 376(59.5) [55.7-63.3] 1418(45.9) [44.1-47.6] 1794(48.2) [46.6-49.8]
Kyangyenyi 1000(56.6) [54.2-58.9] 238 (25.6) [22.8-28.4] 1238(45.9) [44.0-47.8]
Mutara * 1173(35.2) [33.6-36.8] 1173(35.2) [33.5-36.8]
Total 1748(59.5) [57.8-61.3] 5292(37.7) [36.9-38.5] 7040(41.5) [40.7-42.2]
RDT
Burere 20(76.9) [59.6-94.3] 148(56.1) [50.9-62.1] 168(57.9) [52.2-63.7]
Bushenyi 27(79.4) [65.1-93.7] 131(51.8) [45.6-58.0] 158(55.1) [49.3-60.8]
Katerera 20(76.9) [59.6-94.3] 123(51.0) [44.7-57.4] 143(53.6) [47.5-59.6]
Kyamuhumga 26(72.2) [56.9-87.6] 184(54.8) [49.4-60.1] 210(56.5) [51.4-61.5]
Kyeizoba 15(65.2) [44.2-86.3] 116(57.1) [50.3-64.0] 131(58.0) [51.5-64.4]
Total 108(74.5) [67.3-81.7] 702(54.1) [51.4-56.8] 810(56.2) [53.6-58.7]
Microscopy
Bugongi 81(43.1) [35.9-50.2] 146(13.7) [11.7-15.8] 227(18.1) [16.0-20.3]
Kabira 123(47.3) [41.2-53.4] 208(18.3) [16.0-20.5] 331(23.7) [21.4-25.9]
Kabushaho 130(54.9) [48.5-61.2] 234(21.0) [18.6-23.4] 364(26.9) [24.6-29.3]
Kichwamba 123(54.7) [48.1-61.2] 216(23.8) [21.1-26.6] 339(30.0) [27.3-32.6]
Kigarama 107(48.2) [41.6-54.8] 169(15.8) [13.6-17.9] 276(21.3) [19.1-23.6]
Total 564(49.8) [46.9-52.7] 973(18.4) [17.3-19.4] 1537(23.9) [22.9-25.0]
CI = confidence interval, RDT = rapid diagnostic test, *children under-five records missing
Table 3 Prescription of antibiotics in patients with positive RDT or microscopy by age and health centre
Diagnostic method < 5 years
n(%)[95%CI]
≥ 5 years
n(%)[95%CI]
Total
n(%)[95%CI]
RDT
Burere 50(42.7) [33.6-51.8] 104(19.4) [16.0-22.8] 154(23.6) [20.3-26.8]
Bushenyi 29(33.3) [23.2-43.4] 82(17.9) [14.4-21.5] 111(20.4) [17.0-23.8]
Katerera 47(45.2) [35.5-54.9] 115(21.3) [17.9-24.8] 162(25.2) [21.8-28.6]
Kyamuhumga 84(54.2) [46.3-62.1] 162(25.8) [22.3-29.2] 246(31.4) [28.1-34.6]
Kyeizoba 43(35.8) [27.1-44.5] 138(24.3) [20.7-27.8] 181(26.3) [23.0-29.6]
Total 253(43.4) [39.4-47.4] 601(22.0) [20.5-23.6] 854(25.8) [24.3-27.3]
Microscopy
Bugongi 17(34.7) [20.9-48.5] 36(14.2) [9.9-18.6] 53(17.6) [13.2-21.9]
Kabira 23(37.7) [25.2-50.2] 38(12.8) [8.9-16.6] 61(17.0) [13.1-20.9]
Kabushaho 16(38.1) [22.8-53.4] 30(12.1) [8.0-16.2] 46(15.9) [11.6-20.1]
Kichwamba 26(41.9) [29.3-54.6] 39(13.8) [9.8-17.9] 65(18.9) [14.7-23.1]
Kigarama 23(41.8) [28.4-55.3] 25(12.6) [8.0-17.3] 48(19.0) [14.1-23.8]
Total 105(39.0) [33.2-44.9] 168(13.1) [11.3-15.0] 273(17.6) [15.7-19.5]
CI = confidence interval, RDT = rapid diagnostic test
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reduction in antibiotic prescription among patients with
positive malaria test results; there was an increase in
antibiotic treatment in those testing negative; the rate of
antibiotic prescription was higher in children under five
years of age; and antibiotic prescription varied widely
across HCs suggesting that prescribers’ behaviour is a
big factor in use of antibiotics.
The level of antibiotic treatment reported here is
higher than that demonstrated in Kabale [15], a district
in the same region of Uganda with similar malaria ende-
micity, but comparable to that reported in Zanzibar [16].
In this study it is unlikely that symptoms alone justify
this rate of antibiotic prescription as less than 5% of the
patients would probably need antibiotics based on the
clinical presentation. Other reasons such as expectations
of the patient [17], service provider (prescriber) beha-
viour [18] and the social interaction between the patient
and prescriber [17,18] have been cited. It was reported
that for a satisfactory outcome of the consultation pro-
cess, the clinician provides technically correct care, but
this corresponds with the patient’s expectations in order
to legitimize the illness [18]. Also an earlier study [19]
demonstrated that patient preference can stimulate inap-
propriate antibiotic prescribing. Further, other studies
provided information about the other reasons for unne-
cessary antibiotic use [20-22]. Of particular importance
are the inadequate staffing and the varying levels of pro-
fessional training of staff manning outpatient clinics
reported in a previous publication [12]. Understaffing is
impacted by the heavy patient load, creating a need to
finish the queue at the earliest possible time. Some
reports also indicated that overuse of medicines is a con-
sequence of diagnostic uncertainty by service providers,
inappropriate unethical promotion of medicines by phar-
maceutical companies, overworked health staff with
limited time to spend with patients, and unrestricted
availability of medicines [2,21,23]. These results comple-
ment these observations as diagnostic uncertainty and
prescribers’ behaviour were important determinants of
antibiotic use in this study.
Patients who were in the RDT arm were more likely
than those in the microscopy arm to be prescribed anti-
biotics. This difference is unlikely to be attributed to use
of RDT. Generally in the microscopy arm, antibiotic pre-
scription was low among: those not tested, who tested
positive and those who tested negative. The trend of anti-
biotic use, however, was similar in the two diagnostic
arms (decreasing among patients who test positive and
increasing among negative patients). A more likely expla-
nation for this difference in rates of antibiotic use among
the diagnostic arms is prescribers’ behaviour [i.e. higher
likelihood of service providers more likely to treat with
antibiotics in the RDT arm].
The rate of antibiotic prescription generally decreased
among patients with positive results. This might indicate
clinicians’ acceptance of malaria-positive results as the
only likely cause of illness at that point and therefore
restrained from prescribing concurrent medications.
However, the proportion of parasitaemic patients pre-
scribed antibiotics reported here is higher than that
observed in other settings [24]. Enormous resources
have been invested in improving the targeting of anti-
malarials but the concern of concurrent or otherwise
antibiotic treatment has not received equal attention.
Although antibiotic prescription to febrile outpatients
appears complex because of frequent presentation with
multiple complaints, antibiotic treatment in parasitaemic
patients may be an indicator of the likely inability to uti-
lize the clinical guidelines. Antibiotic prescribing for
cough or non-specific upper respiratory tract infections
Table 4 Prescription of antibiotics in patients with negative RDT or microscopy by age and health centre
Diagnostic method < 5 years
n(%)[95%CI]
All age ≥ 5 years
n(%)[95%CI]
Total
n(%)[95%CI]
RDT
Burere 299(80.0) [75.6-83.8] 1258(58.5) [56.4-60.6] 1557(61.7) [59.8-63.6]
Bushenyi 180(81.1) [75.9-86.3] 767(54.0) [51.4-56.6] 947(57.7) [55.3-60.1]
Katerera 285(82.6) [78.6-86.6] 1190(63.0) [60.8-65.2] 1475(66.1) [64.1-68.0]
Kyamuhumga 485(81.1) [78.0-84.3] 1826(60.8) [59.0-62.5] 2311(64.2) [62.6-65.7]
Kyeizoba 353(79.0) [75.2-82.8] 1266(52.8) [50.8-54.7] 1619(56.9) [55.1-58.7]
Total 1602(80.6) [78.9-82.4] 6307(58.1) [57.1-60.0] 7909(61.6) [60.7-62.4]
Microscopy
Bugongi 202(64.9) [59.6-70.3] 470(29.8) [27.5-32.0] 672(35.5) [33.4-37.7]
Kabira 213(65.5) [60.3-70.7] 543(32.7) [30.4-34.9] 756(38.0) [35.9-40.2]
Kabushaho 207(70.7) [65.4-75.9] 570(36.8) [34.4-39.2] 777(42.2) [39.9-44.5]
Kichwamba 189(70.3) [64.8-75.8] 572(39.4) [36.9-41.9] 761(44.2) [41.9-46.6]
Kigarama 195(64.9) [59.6-70.4] 590(33.0) [30.9-35.2] 785(37.6) [35.5-39.7]
Total 1006(67.2) [64.8-69.5] 2745(34.2) [33.2-35.2] 3751(39.4) [38.4-40.4]
CI = confidence interval, RDT = rapid diagnostic test
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was reported to be neither cost-effective nor cough-
effective [25]. Therefore, there is need to enhance the
treatment decisions at the lower level of care since staff
manning these units have varying levels of professional
training.
In this study, the chance of prescribing antibiotics
increased if a febrile patient tested negative for malaria.
These data are similar to what has been reported else-
where [24,26-28]. Thus it appears that there is a compen-
satory antibiotic prescription in patients with negative
results. This scenario of antibiotic prescribing has the
potential to erode the financial savings that could accrue
from widespread implementation of the universal ‘test and
treat’ strategy for malaria. Besides the universal test and
treat strategy does not provide adequate guidance on
treating patients who test negative for malaria. Therefore,
there is need to develop and implement guidelines regard-
ing antibiotic treatment in febrile patients who test nega-
tive for malaria.
In some settings, interventions that promote rational
antibiotic use have been shown to be effective. These
emphasize careful diagnosis especially of upper respira-
tory syndromes, deferral of antibiotic use, and a watch-
and-wait approach (along with symptom relief) for
which antibiotics are not immediately indicated [29],
and a targeted educational intervention [30]. Unless the
use of antibiotics is curtailed, there is a prospect of
higher costs, increased morbidity, and higher rates of
death from common bacterial infections [2].
Conclusions
Prescription of antibiotics in patients with febrile illness is
high. Testing for malaria reduces antibiotic treatment in
patients with positive results but increases in those testing
negative. Antibiotic use also depends on age and prescri-
ber behaviour. It is essential that malaria diagnostics are
rolled-out in all primary level health units and guidelines
for antibiotic treatment especially among children devel-
oped and distributed. In addition, continuing professional
education for prescribers should be enforced.
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